These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26255114)

  • 1. Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.
    Nash KM; Ahmed S
    Nanomedicine; 2015 Nov; 11(8):2033-40. PubMed ID: 26255114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities.
    Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M
    Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease.
    Hasan I; Guo B; Zhang J; Chang C
    Antioxid Redox Signal; 2024 May; 40(13-15):863-888. PubMed ID: 36070437
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery.
    Nagasaki Y
    Ther Deliv; 2012 Feb; 3(2):165-79. PubMed ID: 22834195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases.
    Chen Z; Vong CT; Gao C; Chen S; Wu X; Wang S; Wang Y
    Mol Pharm; 2020 Jul; 17(7):2260-2274. PubMed ID: 32433886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive Oxygen Species (ROS)-Based Nanomedicine.
    Yang B; Chen Y; Shi J
    Chem Rev; 2019 Apr; 119(8):4881-4985. PubMed ID: 30973011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier-mediated antioxidant delivery for liver diseases.
    Li S; Li H; Xu X; Saw PE; Zhang L
    Theranostics; 2020; 10(3):1262-1280. PubMed ID: 31938064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The redox-active nanomaterial toolbox for cancer therapy.
    Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
    Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic strategies to target oxidative stress in heart failure.
    Ahmed Z; Tang WH
    Curr Heart Fail Rep; 2012 Mar; 9(1):14-22. PubMed ID: 22213193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-targeted antioxidant peptides.
    Rocha M; Hernandez-Mijares A; Garcia-Malpartida K; Bañuls C; Bellod L; Victor VM
    Curr Pharm Des; 2010; 16(28):3124-31. PubMed ID: 20687871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
    Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
    Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID.
    Akanchise T; Angelov B; Angelova A
    J Med Virol; 2024 May; 96(5):e29680. PubMed ID: 38767144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss.
    Hajmohammadi Z; Bagher Z; Taghizadeh-Hesary F; Khodadadi M; Masror N; Asghari A; Valipour B; Seifalian A
    Eur J Pharm Biopharm; 2024 Sep; 202():114393. PubMed ID: 38992481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries.
    Yoshitomi T; Nagasaki Y
    Antioxid Redox Signal; 2022 Jan; 36(1-3):70-80. PubMed ID: 34074133
    [No Abstract]   [Full Text] [Related]  

  • 17. Free radicals and antioxidants in normal physiological functions and human disease.
    Valko M; Leibfritz D; Moncol J; Cronin MT; Mazur M; Telser J
    Int J Biochem Cell Biol; 2007; 39(1):44-84. PubMed ID: 16978905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities.
    Jain AK; Mehra NK; Swarnakar NK
    Curr Pharm Des; 2015; 21(30):4441-55. PubMed ID: 26234792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
    Narayanan KB; Park HH
    Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.